BM Report:
Samorita Hospital Ltd., the only publicly traded private hospital in Bangladesh, experienced a sharp decline in profitability during the second quarter of the current fiscal year (FY2023-24). According to a filing with the Dhaka Stock Exchange (DSE), the 250-bed facility’s net profit dropped by a staggering 64% compared to the same period last year, falling to Tk 14.48 lakh (approximately $17,000) from Tk 40.40 lakh.
Earnings per share also took a hit, shrinking from Tk 0.18 to a mere Tk 0.06. However, the healthcare provider offered a glimmer of hope by showcasing a near threefold increase in year-on-year profits for the first half of the financial year, reaching Tk 1.96 crore (approximately $230,000).
This mixed bag of performance did not impress investors, as Samorita’s shares on the DSE dropped 3.18% to Tk 80 by midday. While the broader market, represented by the benchmark DSEX index, experienced a modest gain of 0.07%, the significant fall in Samorita’s share price indicates investor concern regarding the recent profit slump.
The reasons behind the Q2 profit decline remain unclear from the provided information. Further analysis or insights from the hospital’s management would be necessary to understand the factors driving this trend.
This change highlights the complexities and challenges faced by the healthcare sector in Bangladesh, even for established players like Samorita Hospital. The significant drop in profitability despite half-year growth raises questions about the sustainability of the current trend and warrants further investigation into the underlying factors.
